Biotech 2050 Podcast

Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech

17 Dec 2025

Contributed by Lukas

Synopsis: This episode is proudly sponsored by Quartzy. Roivant Sciences CEO Matt Gline returns to Biotech 2050 for a deeply reflective conversatio...

Jay Hartenbach, President & COO, Diakonos Oncology on Reprogramming Cancer Immunity Breakthrough AI

10 Dec 2025

Contributed by Lukas

Synopsis: This episode is proudly sponsored by Quartzy. What happens when engineering discipline, business pragmatism, and breakthrough immunology ...

John Lepore, CEO & President - ProFound Therapeutics, on Proteome, AI, & Bold First-in-Class Drugs

03 Dec 2025

Contributed by Lukas

Synopsis: This episode is proudly sponsored by Quartzy. In this far-reaching conversation, Rahul Chaturvedi speaks with John Lepore, CEO & Presiden...

Jason Kelly - Ginkgo Bioworks CEO and Co-Founder on Automation, AI Data & Biotech’s Reset

25 Nov 2025

Contributed by Lukas

Synopsis: This episode is proudly sponsored by Quartzy. Biotech is undergoing a scientific redesign, and Jason Kelly reveals to host Alok Tayi how ...

Arun Swaminathan: Coya CEO on Neuroinflammation, BD Strategy & Patient-Driven Biotech

20 Nov 2025

Contributed by Lukas

Synopsis: In a conversation rich with strategic insight, Coya Therapeutics CEO Arun Swaminathan unpacks the intersections of scientific innovation, ...

How Nimbus CEO Abbas Kazimi Builds Resilient Pipelines Through Culture, Rigor & Smart Bets

13 Nov 2025

Contributed by Lukas

Synopsis: Nimbus Therapeutics CEO Abbas Kazimi walks Alok Tayi through the company’s evolving pipeline and playbook for choosing the right risks i...

Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value

05 Nov 2025

Contributed by Lukas

Synopsis: Jim Tananbaum, Founder & CEO of Foresite Capital, joins Rahul Chaturvedi to dissect the patterns driving biotech innovation, the role of m...

Geoffrey Duyk, Grove Biopharma CEO, on Polymer Breakthroughs, Intractable Targets & Biotech's Future

23 Oct 2025

Contributed by Lukas

Synopsis: Host Rahul Chaturvedi sits down with Geoffrey Duyk, Chief Executive Officer of Grove Biopharma, for a wide-ranging conversation on navigat...

Syndax CEO Michael Metzger on Bold Leadership, Dual Drug Launches & Redefining Cancer Care

08 Oct 2025

Contributed by Lukas

Synopsis: Few biotechs can pull off what Syndax Pharmaceuticals has achieved — two first-in-class oncology drug launches, built entirely through s...

Co-creating Breakthroughs in R&D: Paul Biondi (Flagship) & Uli Stilz (Novo Nordisk)

30 Sep 2025

Contributed by Lukas

Synopsis: When biotech meets bold partnerships, new models of innovation emerge. In this episode of the Biotech 2050 Podcast, host Rahul Chaturvedi ...

Kevin Caldwell, Ossium Health CEO, on Cell Therapy, Vertical Integration & Immune Healthspan

21 Aug 2025

Contributed by Lukas

Synopsis: From stargazing in rural Tennessee to reimagining the future of immune health, Kevin Caldwell’s journey is anything but conventional. In...

Rewriting Cancer: AmirAli Talasaz, Co-CEO of Guardant Health, on Liquid Biopsy, Data & Biotech Grit

14 Aug 2025

Contributed by Lukas

Synopsis: Some of the most game-changing ideas in healthcare come from unexpected intersections—where engineering meets biology, and where data me...

Terns CEO Amy Burroughs on CML Innovation, Obesity Drug Breakthroughs & Leading Biotech Forward

31 Jul 2025

Contributed by Lukas

Synopsis: Amy Burroughs, CEO of Terns Pharmaceuticals, joins Alok Tayi to share how she’s leading bold innovation in CML and obesity treatment, dri...

Jeremy Bender, Day One CEO, on Transforming Pediatric Cancer Care & Leading Biotech with Purpose

23 Jul 2025

Contributed by Lukas

Synopsis: Host Rahul Chaturvedi sits down with Jeremy Bender, CEO of Day One Biopharmaceuticals, to explore the bold mission of transforming pediatri...

Ahmed Mousa, Vicore CEO, on IPF Breakthroughs, AI-Powered Drug Discovery & Global Biotech Leadership

16 Jul 2025

Contributed by Lukas

Synopsis: What do courtroom litigation, computational biology, and fibrosis drug development have in common? In this episode of Biotech 2050, host Al...

Curran Simpson, President & CEO of REGENXBIO, on Gene Therapy, Strategy & Patient-Centered Impact

08 Jul 2025

Contributed by Lukas

Synopsis: When an introverted engineer becomes the President & CEO of REGENXBIO, transformation follows. Curran Simpson joins host Rahul Chaturvedi ...

Sergey Jakimov, Founding Partner at LongeVC, on Pragmatic Longevity Investing & Biotech Innovation

02 Jul 2025

Contributed by Lukas

Synopsis: Longevity isn’t just about living longer—it’s about living better. In this insightful episode of Biotech 2050, host Alok Tayi sits do...

Dr. Howard Fillit & Mark Roithmayr of ADDF on Alzheimer’s Innovation, Funding & Biomarkers

17 Jun 2025

Contributed by Lukas

Synopsis: What happens when a world-class scientist and a philanthropic legacy collide with one of medicine’s greatest challenges? Dr. Howard Fillit...

Stacy Lindborg, Imunon President & CEO, on Bold Biotech, IL-12 Immunotherapy & Phase 3 Trials

14 May 2025

Contributed by Lukas

Synopsis: What does bold biotech leadership look like in 2025? In this episode of Biotech 2050, host Alok Tayi sits down with Stacy Lindborg, Presi...

Stephanie Sirota, CBO & Partner at RTW Investments, on Biotech Investing, Policy & Bold Bet Building

08 May 2025

Contributed by Lukas

Synopsis: What happens when a former journalist becomes one of biotech’s boldest investors? Meet Stephanie Sirota, Chief Business Officer and Part...

Steve Tregay on Leading Mission BioCapital as Managing Partner & Fueling Early-Stage Biotech

03 Apr 2025

Contributed by Lukas

Synopsis: Building in biotech isn’t for the faint of heart—especially during a market downturn. But that’s exactly when Steve Tregay, Managi...

Neil F. McFarlane, President & CEO of Zevra Therapeutics, on Leading Rare Disease Innovation

26 Mar 2025

Contributed by Lukas

Synopsis: In this episode of Biotech2050, host Rahul Chaturvedi sits down with Neil F. McFarlane, President and CEO of Zevra Therapeutics, to explor...

Raj Devraj, President & CEO - Rectify Pharma, on Drug Discovery, Biotech Breakthroughs & Growth

20 Mar 2025

Contributed by Lukas

Synopsis: How do you build a biotech company that disrupts drug discovery and delivers real impact? In this episode of Biotech 2050, host Rahul Chat...

Revolutionizing CAR T with CRISPR: Rachel Haurwitz, President & CEO of Caribou Biosciences

11 Mar 2025

Contributed by Lukas

Synopsis: Host Rahul Chaturvedi welcomes back Rachel Haurwitz, President & CEO of Caribou Biosciences, for a deep dive into the future of CRISPR-bas...

Liam Killingstad on How Family Offices Quietly Fuel Biotech’s Boldest Innovations

06 Mar 2025

Contributed by Lukas

Synopsis: In this thought-provoking episode of Biotech 2050, host Alok Tayi sits down with Liam Killingstad, Member at Finiam Investments, to unpack...

Clare Terlouw, Head of LifeArc Ventures, on Bridging Biotech’s Funding Gap & Investing for Impact

26 Feb 2025

Contributed by Lukas

Synopsis: Host Alok Tayi sits down with Clare Terlouw, Head of Ventures at LifeArc Ventures, to explore biotech investing from an LP perspective. Cl...

AI, Biotech, & Venture Capital: Alex Bangash, Founder of Transpose, on Future of Startup Investing

20 Feb 2025

Contributed by Lukas

Synopsis: Venture capital is evolving, and so is biotech. In this episode of Biotech 2050, host Alok Tayi, CEO and co-founder of VibeBio, sits down ...

Empowering Neurodivergent Innovators: Chad Belinsky on Impact, Mentorship, and Atypical Path

12 Feb 2025

Contributed by Lukas

Synopsis: In this special episode of Biotech 2050, Host Alok Tayi, CEO and Co-Founder of VibeBio, delves into the world of neurodivergent entreprene...

Biotech Venture Investing with Narayan Chowdhury, Co-Founder of Franklin Park LLC

06 Feb 2025

Contributed by Lukas

Synopsis: In this episode of Biotech 2050, host Alok Tayi explores the world of biotech venture capital with Narayan Chowdhury, Co-Founder of Frankl...

David Meeker, CEO of Rhythm Pharmaceuticals, on Rare Disease Breakthroughs & Biotech’s Future

29 Jan 2025

Contributed by Lukas

Synopsis: Join host Alok Tayi as he welcomes David Meeker, CEO of Rhythm Pharmaceuticals, for an inspiring conversation on the transformative journe...

Pioneering Advances in Cell Therapy: Kristin Yarema, President & CEO of Poseida Therapeutics

20 Nov 2024

Contributed by Lukas

Synopsis: Host Rahul Chaturvedi leads an insightful conversation with Dr. Kristin Yarema, President and CEO of Poseida Therapeutics. Kristin shares ...

Bharatt Chowrira, CEO & Eric Elenko, CoFounder & President of PureTech on Biotech Growth

13 Nov 2024

Contributed by Lukas

Synopsis: In this insightful conversation on Biotech2050, host Rahul Chaturvedi sits down with Bharatt Chowrira, CEO, and Eric Elenko, Co-Founder an...

Rob Williamson, CEO of Triumvira, on Biotech’s High-Stakes Path and Cell Therapy Innovations

06 Nov 2024

Contributed by Lukas

Synopsis: Rob Williamson, CEO of Triumvira, joins Biotech 2050 host, Rahul Chaturvedi, to discuss his dynamic career from economics to biotech, tack...

Gene Mack, Interim CEO & CFO of Gain Therapeutics: Leading the Charge in Parkinson's Breakthroughs

30 Oct 2024

Contributed by Lukas

Biotech2050 Host, Rahul Chaturvedi, engages with Gene Mack, Interim CEO and CFO of Gain Therapeutics, as he shares his journey from aspiring neurosurg...

Revolutionizing Heart Health: Bitterroot Bio’s Bold Vision with CEO Pavan Cheruvu

23 Oct 2024

Contributed by Lukas

Synopsis: Discover how Bitterroot Bio is poised to revolutionize cardiovascular health in this captivating conversation between host Rahul Chaturved...

Inside the Journey of Abcuro: CEO Alex Martin on Leadership, IBM, and the Future of Biotech

17 Oct 2024

Contributed by Lukas

Synopsis: In this episode of Biotech 2050, Alex Martin, CEO of Abcuro, sits down with host Rahul Chaturvedi to share his inspiring journey from aspi...

Precision Neuroscience Breakthroughs: Abe Ceesay, CEO of Rapport Therapeutics I Future of Biotech

11 Oct 2024

Contributed by Lukas

Synopsis: Abe Ceesay, CEO of Rapport Therapeutics, sits down with host Rahul Chaturvedi to reveal how precision neuroscience is driving revolutionar...

Dr. Dave Bearss, Co-Founder & CEO of Halia, on Pioneering Genetic Discoveries to Defeat Alzheimer’s

04 Oct 2024

Contributed by Lukas

Synopsis: Explore the forefront of biotech innovation as host Rahul Chaturvedi interviews Dr. Dave Bearss, Co-Founder & CEO of Halia Therapeutics, i...

Breaking Biotech Barriers: Avidity President & CEO Sarah Boyce on RNA’s Next Frontier

19 Sep 2024

Contributed by Lukas

Synopsis: In this episode, host Rahul Chaturvedi interviews Sarah Boyce, President & CEO of Avidity Biosciences, as she shares her dynamic journey f...

Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity

28 Aug 2024

Contributed by Lukas

Synopsis: Step into the future of biotech as host Rahul Chaturvedi delves into an exclusive conversation with Fabrice Chouraqui, CEO of Cellarity, as...

Redefining Dementia Care: CervoMed's Bold Journey with CEO John Alam

15 Aug 2024

Contributed by Lukas

Synopsis: Get ready for an insightful conversation as host Rahul Chaturvedi connects with John Alam, CEO of CervoMed, to uncover the revolutionary ad...

From Banking to Biotech: Renée Aguiar-Lucander, CEO of Calliditas, on Rare Disease Innovation

06 Aug 2024

Contributed by Lukas

Synopsis: Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, appears on this insightful episode of Biotech 2050 with host Rahul Chaturvedi. René...

Autoimmune Innovations: Insights from Marshall Fordyce, Founder & CEO, Vera Therapeutics on Biotech

01 Aug 2024

Contributed by Lukas

Synopsis: In this engaging episode, host, Rahul Chaturvedi welcomes Marshall Fordyce, Founder and CEO of Vera Therapeutics, to discuss his transform...

Transforming Gene Therapy: Exclusive Insights from Zandy Forbes, President & CEO of MeiraGTx

24 Jul 2024

Contributed by Lukas

Synopsis: Zandy Forbes, Founder, President, and CEO of MeiraGTx, joins host Rahul Chaturvedi in this compelling episode. Zandy shares her inspiring ...

Biotech Breakthroughs: Jeb Keiper, CEO of Nimbus Therapeutics, Discusses Their Innovative Journey

17 Jul 2024

Contributed by Lukas

Synopsis: Dive into this episode of Biotech 2050 where host Rahul Chaturvedi interviews Jeb Keiper, CEO of Nimbus Therapeutics. Discover Jeb's fascin...

Revolutionizing Proteomics: Sujal Patel, Co-Founder & CEO of Nautilus, on Drug Development

11 Jul 2024

Contributed by Lukas

Synopsis: Sujal Patel, co-founder and CEO of Nautilus Biotechnology, discusses their innovative work in proteomics and its impact on drug development...

Exploring Neuroscience, Psychiatry, & Rare Diseases, Bruce Leuchter, President & CEO, Neurvati

13 Jun 2024

Contributed by Lukas

Synopsis: In this episode of Biotech 2050, host Alok Tayi, CEO and co-founder of Vibe Bio, speaks with Dr. Bruce Leuchter, President and CEO of Neur...

Transformative Oncology Innovations, Ken Keller, President & CEO, Daiichi Sankyo, Inc.

06 Jun 2024

Contributed by Lukas

Synopsis: In this episode of BioTech 2050, Ken Keller, President and CEO of Daiichi Sankyo, Inc. provides an in-depth look into the company's transf...

Strategic Leadership and Autoimmune Breakthroughs, Praveen Tipimeni, CEO

23 May 2024

Contributed by Lukas

Synopsis: In this episode of Biotech2050, Praveen Tipirneni, CEO of Morphic Therapeutics, shares insights on Morphic’s strategic IPO, the rising in...

Innovative Approaches to Cancer Therapies, Robert Ang, President and CEO

15 May 2024

Contributed by Lukas

Synopsis: In this episode of BioTech 2050, Robert Ang, CEO of Vor Bio, shares insights on the current state of cancer therapies and next-gen modalit...

Tech-Biotech Convergence, Growth, and Global Lessons, Vik Bajaj, Co-founder and CEO

08 May 2024

Contributed by Lukas

Synopsis: In this episode of Biotech2050, Vik Bajaj, Co-founder and CEO of Foresite Labs, delves into the convergence of tech and biotech, hyper-gro...

Advancing and Revolutionizing Sickle Cell Treatment, Ted Love, Chair and BOD

02 May 2024

Contributed by Lukas

Synopsis: In this episode of Biotech2050, Dr. Ted Love, former CEO of Global Blood Therapeutics and Current Chairman of BIO, shares insights on sickl...

Demystifying Drug Discovery, Ray Stevens, CEO, Structure Therapeutics

03 Apr 2024

Contributed by Lukas

Synopsis: In this episode of the Biotech 2050 podcast, host Rahul Chaturvedi engages in a thought-provoking conversation with Ray Stevens, a prominen...

Navigating The Evolving Landscape of Inflammation Research, Scott Megaffin, CEO, Adiso Therapeutics

27 Mar 2024

Contributed by Lukas

Synopsis: In this episode of Biotech2050, Scott Megaffin, CEO of Adiso Therapeutics, shares valuable insights on the challenges and opportunities in ...

Biotech's Game Changers & Revolutionizing Therapeutics, Dr. Mammen, CEO, FogPharma

20 Mar 2024

Contributed by Lukas

Synopsis: In this episode of the Biotech2050 podcast, Dr. Mathai Mammen, CEO of FogPharma, shares valuable insights into the future trends of the bio...

The Race to Cure Untreatable Cancers, Ken Galbraith, Chair and CEO, Zymeworks

13 Mar 2024

Contributed by Lukas

Synopsis: In the recent episode of Biotech2050, Ken Galbraith, CEO of Zymeworks, shares profound insights into the biotech industry, leadership, and ...

Innovation in Precision Therapies for CNS Diseases, Craig Chambliss, Co-Founder and CEO, Neurelis

06 Mar 2024

Contributed by Lukas

Synopsis: In this episode of Biotech2050, host Alok Tayi engages in a profound conversation with Craig Chambliss, CEO and co-founder of Neurellis, de...

Unlocking Genetic Medicine's Full Potential, Tuyen Ong, CEO, Ring Therapeutics

28 Feb 2024

Contributed by Lukas

Synopsis: On the Biotech2050 podcast, Tuyen Ong, CEO at Ring Therapeutics and CEO partner at flagship pioneering, shared his journey from a medical b...

Aging Biology and The Power of Human Data, Kristen Fortney, Co-Founder and CEO, BioAge

21 Feb 2024

Contributed by Lukas

Synopsis: In a recent episode of Biotech2050, hosted by Alok Tayi, Kristen Fortney, CEO of BioAge, provides valuable insights into the evolving lands...

The Intersection Of Tech and Biotech, Chris Gibson, Co-Founder & CEO, Recursion

14 Feb 2024

Contributed by Lukas

Synopsis: In this episode of the Biotech2050 podcast, Chris Gibson, the co-founder and CEO of Recursion, shares insights on the intersection of techn...

Psychedelics, Longevity, and Wellbeing, Christian Angermayer, Founder, Apeiron Investment Group

07 Feb 2024

Contributed by Lukas

Synopsis: Christian Angermayer, a prominent investor and entrepreneur in the biotech industry, shares valuable insights in the Biotech2050 podcast, s...

Navigating Platform vs Product Tension, David Kirn, Co-Founder & CEO, 4DMT

31 Jan 2024

Contributed by Lukas

Synopsis: In this episode of the Biotech2050 podcast, David Kirn, CEO of 4D Molecular Therapeutics, shares invaluable insights for aspiring entrepren...

Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics

10 Jan 2024

Contributed by Lukas

Synopsis: In this episode of the Biotech2050 podcast, David Esposito, CEO of ONL Therapeutics, provides valuable insights into the challenges and oppo...

Overcoming Capital Challenges in Biotech, Jak Knowles, President & CEO, Affini-T Therapeutics

13 Dec 2023

Contributed by Lukas

Synopsis: In this episode of the Biotech2050 podcast, Jak Knowles, co-founder of Affini-T Therapeutics, shares valuable insights into the challenges ...

A novel approach to advancing breast cancer therapy, Sean Bohen, President & CEO, Olema Oncology

06 Dec 2023

Contributed by Lukas

Synopsis: Sean Bohen, M.D., Ph.D., is the President and CEO of Olema Oncology, a biopharmaceutical company developing innovative targeted therapies f...

The promise of precision oncology, Troy Wilson, President & CEO, Kura Oncology

29 Nov 2023

Contributed by Lukas

Synopsis: Troy Wilson, Ph.D., J.D., is the President and CEO of Kura Oncology, a clinical-stage biopharmaceutical company committed to realizing the ...

Next-gen gene editing, Keith Gottesdiener, President & CEO, Jeremy Duffield, CSO, Prime Medicine

22 Nov 2023

Contributed by Lukas

Synopsis: Keith Gottesdiener, MD, and Jeremy Duffield, MD, PhD, FRCP, are the President & CEO and CSO, respectively, of Prime Medicine. Prime Medicin...

Developing medicines for broad populations of cancer patients, Brett Hall, CSO, Immuneering

15 Nov 2023

Contributed by Lukas

Synopsis: Brett Hall, Ph.D., is the CSO of Immuneering, a public, clinical-stage oncology company dedicated to developing medicines for broad populat...

Harnessing the power of microglia, Ivana Magovčević-Liebisch, President & CEO, Vigil Neuroscience

08 Nov 2023

Contributed by Lukas

Synopsis: Ivana Magovčević-Liebisch, PhD, JD, is the President and CEO of Vigil Neuroscience, a microglia-focused company dedicated to improving th...

Revolutionizing eyecare treatment, Bobak Azamian, CEO & Chairman, Tarsus Pharmaceuticals

01 Nov 2023

Contributed by Lukas

Synopsis: Bobak Azamian, MD, Ph.D., is the CEO and Chairman of Tarsus Pharmaceuticals, a biopharmaceutical company that applies proven science and ne...

Targeting validated drivers of cancer, Nima Farzan, CEO, Kinnate Biopharma

25 Oct 2023

Contributed by Lukas

Synopsis: Nima Farzan is the CEO of Kinnate Biopharma, a clinical-stage precision oncology company focused on expanding on the promise of targeted th...

Advancing bold therapies for neuronal health, Mark Litton, President & CEO, Athira Pharma

18 Oct 2023

Contributed by Lukas

Synopsis: Mark Litton, Ph.D., is the President and CEO of Athira Pharma, a late clinical-stage biopharmaceutical company focused on developing small ...

Pioneering RNA editing to deliver the future of medicine, Ram Aiyar, President & CEO, Korro Bio

11 Oct 2023

Contributed by Lukas

Synopsis: Ram Aiyar, Ph.D., MBA, is the President & CEO of Korro Bio. Korro Bio harnesses the body’s natural RNA editing machinery to make precise,...

Unlocking the technological potential of biology, Seemay Chou, Co-Founder & CEO, Arcadia Science

04 Oct 2023

Contributed by Lukas

Synopsis: Seemay Chou, Ph.D., is the Co-Founder and CEO of Arcadia Science, a research and development company leveraging the biology of emerging res...

Pioneering tRNA therapeutics, Michelle Werner, CEO, Alltrna & CEO-Partner, Flagship Pioneering

27 Sep 2023

Contributed by Lukas

Synopsis: Michelle Werner is the CEO of Alltrna and a CEO-Partner at Flagship Pioneering. Alltrna is the world’s first tRNA platform company to de...

Breaking new ground in the treatment of fibrosis, Bernard Coulie, President & CEO, Pliant Tx

20 Sep 2023

Contributed by Lukas

Synopsis: Bernard Coulie is the President and CEO of Pliant Therapeutics, a clinical stage biopharmaceutical company focused on discovering and devel...

Transforming medicine through precision epigenomic control, Mahesh Karande, Pres. & CEO, Omega Tx

13 Sep 2023

Contributed by Lukas

Synopsis: Mahesh Karande is the President and CEO of Omega Therapeutics, a clinical-stage biotechnology company pioneering the development of a new c...

Catalyzing the next generation of mRNA medicines, Joseph Payne, Founder, Pres. & CEO, Arcturus Tx

06 Sep 2023

Contributed by Lukas

Synopsis: Joseph Payne is the Founder, President and CEO of Arcturus Therapeutics, a global late-stage clinical messenger RNA medicines and vaccines ...

Advancing muscle biology, Robert Blum, Pres. & CEO, & Fady Malik, EVP, Research & Dev., Cytokinetics

30 Aug 2023

Contributed by Lukas

Synopsis: Robert Blum and Fady Malik are the President & CEO and EVP, Research and Development, respectively, of Cytokinetics, ​​a late-stage bio...

Transforming the treatment of neuromuscular diseases, James McArthur, CEO, PepGen

23 Aug 2023

Contributed by Lukas

Synopsis: James McArthur is the CEO of PepGen, a biotech company creating a pipeline of disease-modifying therapeutics with the potential to safely a...

Conquering new frontiers in cell therapy, Paul Lammers, CEO, Triumvira Immunologics

16 Aug 2023

Contributed by Lukas

Synopsis: Paul Lammers, M.D., is the CEO of Triumvira Immunologics, a clinical-stage immuno-oncology company developing unique, targeted autologous ...

Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma

09 Aug 2023

Contributed by Lukas

Synopsis: Andrew Scharenberg is the Co-founder and CEO of Umoja Biopharma, a company pioneering the future of immunotherapy by reprogramming T cells ...

Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx

02 Aug 2023

Contributed by Lukas

Synopsis: Theresa Heah, M.D., is the CEO of Intergalactic Therapeutics. Intergalactic is overcoming the limitations of viral-based gene therapy and d...

Transforming diseased cells into coordinators of cure, Volker Herrmann, President & CEO, Sonata Tx

26 Jul 2023

Contributed by Lukas

Synopsis: Volker Herrmann is the President and CEO of Sonata Therapeutics, a Flagship Pioneering company revolutionizing the world’s understanding...

Breaking barriers in rare genetic mitochondrial diseases, Greg Flesher, Pres. & CEO, Reneo

19 Jul 2023

Contributed by Lukas

Synopsis: Greg Flesher is the President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of ther...

Correcting abnormal gene expression in oncology, Adrian Gottschalk, Pres. & CEO, Foghorn Tx

12 Jul 2023

Contributed by Lukas

Synopsis: Adrian Gottschalk is the president and CEO of Foghorn Therapeutics, a clinical-stage biotechnology company pioneering a new class of medic...

Epigenetic therapies for organ injury & chronic liver diseases, Jim Brown, Pres. & CEO, DURECT

05 Jul 2023

Contributed by Lukas

Synopsis: Jim Brown is the President and CEO of DURECT Corporation, a biopharmaceutical company committed to transforming the treatment of acute org...

New vision for preventing & curing age-related diseases, James Peyer, Founder & CEO, Cambrian Bio

28 Jun 2023

Contributed by Lukas

Synopsis: James Peyer, Ph.D., is the Founder and CEO of Cambrian Bio, a clinical-stage drug-development company focused on creating therapies to prev...

Revolutionizing T-cells for solid tumor cell therapies, Gary Lee, CSO, Lyell Immunopharma

21 Jun 2023

Contributed by Lukas

Synopsis: Gary Lee, Ph.D. is the CSO of Lyell Immunopharma, a T-cell reprogramming company dedicated to developing cell therapies for patients with ...

Mobilizing the immune system to combat disease, Liang Schweizer, Founder & CEO, HiFiBiO Tx

14 Jun 2023

Contributed by Lukas

Synopsis: Liang Schweizer, Ph.D. is the Founder and CEO of HiFiBiO Therapeutics, a clinical-stage global biotech company mobilizing the human immune...

BIO Special: New vision for immunotherapy, Detlev Biniszkiewicz, Founder & CEO, NextPoint Tx

07 Jun 2023

Contributed by Lukas

Synopsis: Detlev Biniszkiewicz is the Founder and CEO of NextPoint Therapeutics, a company advancing the field of immuno-oncology through its leading...

BIO Special: Advancing kidney disease care, Eric Dobmeier, President & CEO, Chinook Tx

06 Jun 2023

Contributed by Lukas

Synopsis: Eric Dobmeier is the President and CEO of Chinook Therapeutics, a clinical-stage biopharmaceutical company discovering, developing and com...

BIO Special: Advancing heart disease treatment, Faraz Ali, CEO, Tenaya Therapeutics

05 Jun 2023

Contributed by Lukas

Synopsis: Faraz Ali is the CEO of Tenaya Therapeutics, a clinical-stage biotechnology company with a mission to discover, develop and deliver potenti...

Drugging the undruggable with Gregory Verdine, Co-Founder, President & CEO, Lifemine Tx & FogPharma

31 May 2023

Contributed by Lukas

Synopsis: Gregory Verdine, Ph.D., is the Co-Founder, President and CEO of LifeMine Therapeutics and FogPharma. LifeMine Therapeutics is reinventing ...

Pioneering precision therapies for cancer & blood disorders, Kate Haviland, CEO, Blueprint Medicines

30 May 2023

Contributed by Lukas

Synopsis: Kate Haviland is the CEO of Blueprint Medicines, a global precision therapy company that creates life-changing medicines for people with c...

Targeting highly dynamic proteins to develop precision medicines, Asit Parikh, Pres. & CEO, MOMA Tx

24 May 2023

Contributed by Lukas

Synopsis: Asit Parikh, M.D., Ph.D., is the President and CEO of MOMA Therapeutics, a biotech company discovering the next generation of precision med...

RNA-guided programmable therapeutics for fibrosis, Samir Ounzain, CEO & Co-Founder, HAYA Tx

17 May 2023

Contributed by Lukas

Synopsis: Samir Ounzain is the CEO and Co-Founder of HAYA Therapeutics, a precision medicines company developing RNA-guided programmable therapeutic...

Single-course gene editing for cardiovascular disease, Sekar Kathiresan, Co-Founder & CEO, Verve Tx

10 May 2023

Contributed by Lukas

Synopsis: Sekar Kathiresan is the Co-Founder, CEO and Board Member of Verve Therapeutics, a clinical-stage biotechnology company developing gene edit...

Leading personalized immune medicines, Harlan Robins, CSO & Co-Founder, Adaptive Biotechnologies

03 May 2023

Contributed by Lukas

Synopsis: Harlan Robins, Ph.D., is the CSO and Co-Founder of Adaptive Biotechnologies, a pioneer and leader in immune-driven medicine that aims to im...

Advancing RNA medicines in genetic diseases, Paul Bolno, President & CEO, Wave Life Sciences

26 Apr 2023

Contributed by Lukas

Synopsis: Dr. Paul Bolno is the President and CEO of Wave Life Sciences, a clinical-stage RNA medicines company committed to delivering life-changing...